Literature DB >> 1738923

Beneficial effects of cyclosporine on postischemic liver injury in rats.

T Kurokawa1, H Kobayashi, T Nonami, A Harada, A Nakao, S Sugiyama, T Ozawa, H Takagi.   

Abstract

The discovery of cyclosporine has had a significant impact on preventing the rejection of transplanted organs in humans. In this study, we present another positive aspect of cyclosporine. Rats were pretreated with cyclosporine (10 mg/kg, i.v.), or untreated. After 2-hr ischemia or 1 hr of reperfusion following 2-hr ischemia, livers were isolated and liver adenine nucleotide concentrations were determined. Liver mitochondria were prepared and their function was estimated polarographically. Leakage of AST, ALT, LDH, and adenine nucleotides into the hepatic vein just after reperfusion was also measured. Cyclosporine treatment did not affect ischemia-induced mitochondrial dysfunction, nor did it prevent the associated decrease in adenosine triphosphate concentration. However, treatment with cyclosporine accelerated the recovery of mitochondrial function and of tissue adenosine triphosphate concentrations. Cyclosporine treatment also mitigated leakage of AST, ALT, LDH, and adenine nucleotides after reperfusion. These results indicate that cyclosporine shows a potent protective effect on ischemia-reperfusion-related liver injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738923     DOI: 10.1097/00007890-199202010-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Perspectives on the mitochondrial multiple conductance channel.

Authors:  K W Kinnally; T A Lohret; M L Campo; C A Mannella
Journal:  J Bioenerg Biomembr       Date:  1996-04       Impact factor: 2.945

2.  Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury.

Authors:  Joshua Hefler; Braulio A Marfil-Garza; Sandra Campbell; Darren H Freed; A M James Shapiro
Journal:  Ann Transl Med       Date:  2022-09

3.  Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.

Authors:  Satoshi Kuboki; Nozomu Sakai; Johannes Tschöp; Michael J Edwards; Alex B Lentsch; Charles C Caldwell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-05       Impact factor: 4.052

4.  Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.

Authors:  Courtney M Lappas; Yuan-Ji Day; Melissa A Marshall; Victor H Engelhard; Joel Linden
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

Review 5.  Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.

Authors:  Ricardo O S Soares; Daniele M Losada; Maria C Jordani; Paulo Évora; Orlando Castro-E-Silva
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.